The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder

The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n  = 236). T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 1999-11, Vol.4 (6), p.580-586
Hauptverfasser: Rowe, D C, Van den Oord, E J C G, Stever, C, Giedinghagen, L N, Gard, J M C, Cleveland, H H, Gilson, M, Terris, S T, Mohr, J H, Sherman, S, Abramowitz, A, Waldman, I D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 586
container_issue 6
container_start_page 580
container_title Molecular psychiatry
container_volume 4
creator Rowe, D C
Van den Oord, E J C G
Stever, C
Giedinghagen, L N
Gard, J M C
Cleveland, H H
Gilson, M
Terris, S T
Mohr, J H
Sherman, S
Abramowitz, A
Waldman, I D
description The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n  = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h 2  = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.
doi_str_mv 10.1038/sj.mp.4000567
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69333900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2645752023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</originalsourceid><addsrcrecordid>eNpt0Mlr3DAUB2BRGpqlPfZaBC25earVso4l6RIIBNLpWbyR5I4Gy3IkT8H_fTTMQErpSYL3vYUfQu8pWVHCu89lt4rTShBCZKteoQsqVNtIqbrX9c-lbgTtxDm6LGVHyKEo36BzSipggl6gn-utx7ePtwyv4ekOT2lYYsrTNpSIYXS4LHGaUyw49Rjm2Y9zSCN2vg82zHi7TD6DncOfMC_YhZKy8_ktOuthKP7d6b1Cv759Xd_8aO4fvt_dfLlvLFNUNdo5rbpWa07sBpTnbiMYbxVxsFHggSjoPYBnoFvNNdW9oJxBK4DbzkvPr9D1ce6U09Pel9nEUKwfBhh92hdTuzjXhFT48R-4S_s81tsMa4VUkhHGq2qOyuZUSva9mXKIkBdDiTlkbcrOxMmcsq7-w2nqfhO9-0sfw63g0wlAsTD0GUYbyoujHefysHd1ZKVWxt8-v1z3_8XP2PaWlQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645752023</pqid></control><display><type>article</type><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</creator><creatorcontrib>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</creatorcontrib><description>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n  = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h 2  = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/sj.mp.4000567</identifier><identifier>PMID: 10578241</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adolescent ; Adult ; Alleles ; Attention Deficit Disorder with Hyperactivity - genetics ; Attention deficit disorders. Hyperactivity ; Attention deficit hyperactivity disorder ; Behavioral Sciences ; Biological and medical sciences ; Biological Psychology ; Brain Chemistry - genetics ; Child ; Child clinical studies ; Children ; Dopamine D2 receptors ; Family Health ; Female ; Gene polymorphism ; Genetic Linkage ; Genotype ; Heritability ; Humans ; Hyperactivity ; Male ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Neurosciences ; original-research-article ; Pharmacotherapy ; Polymorphism ; Polymorphism, Genetic ; Population genetics ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Receptors, Dopamine D2 - genetics ; Siblings ; Statistical analysis ; Taq Polymerase</subject><ispartof>Molecular psychiatry, 1999-11, Vol.4 (6), p.580-586</ispartof><rights>Macmillan Publishers Limited 1999</rights><rights>2000 INIST-CNRS</rights><rights>Macmillan Publishers Limited 1999.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.mp.4000567$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.mp.4000567$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27904,27905,41468,42537,51299</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1183353$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10578241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rowe, D C</creatorcontrib><creatorcontrib>Van den Oord, E J C G</creatorcontrib><creatorcontrib>Stever, C</creatorcontrib><creatorcontrib>Giedinghagen, L N</creatorcontrib><creatorcontrib>Gard, J M C</creatorcontrib><creatorcontrib>Cleveland, H H</creatorcontrib><creatorcontrib>Gilson, M</creatorcontrib><creatorcontrib>Terris, S T</creatorcontrib><creatorcontrib>Mohr, J H</creatorcontrib><creatorcontrib>Sherman, S</creatorcontrib><creatorcontrib>Abramowitz, A</creatorcontrib><creatorcontrib>Waldman, I D</creatorcontrib><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n  = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h 2  = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Alleles</subject><subject>Attention Deficit Disorder with Hyperactivity - genetics</subject><subject>Attention deficit disorders. Hyperactivity</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Behavioral Sciences</subject><subject>Biological and medical sciences</subject><subject>Biological Psychology</subject><subject>Brain Chemistry - genetics</subject><subject>Child</subject><subject>Child clinical studies</subject><subject>Children</subject><subject>Dopamine D2 receptors</subject><subject>Family Health</subject><subject>Female</subject><subject>Gene polymorphism</subject><subject>Genetic Linkage</subject><subject>Genotype</subject><subject>Heritability</subject><subject>Humans</subject><subject>Hyperactivity</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosciences</subject><subject>original-research-article</subject><subject>Pharmacotherapy</subject><subject>Polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Population genetics</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Siblings</subject><subject>Statistical analysis</subject><subject>Taq Polymerase</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0Mlr3DAUB2BRGpqlPfZaBC25earVso4l6RIIBNLpWbyR5I4Gy3IkT8H_fTTMQErpSYL3vYUfQu8pWVHCu89lt4rTShBCZKteoQsqVNtIqbrX9c-lbgTtxDm6LGVHyKEo36BzSipggl6gn-utx7ePtwyv4ekOT2lYYsrTNpSIYXS4LHGaUyw49Rjm2Y9zSCN2vg82zHi7TD6DncOfMC_YhZKy8_ktOuthKP7d6b1Cv759Xd_8aO4fvt_dfLlvLFNUNdo5rbpWa07sBpTnbiMYbxVxsFHggSjoPYBnoFvNNdW9oJxBK4DbzkvPr9D1ce6U09Pel9nEUKwfBhh92hdTuzjXhFT48R-4S_s81tsMa4VUkhHGq2qOyuZUSva9mXKIkBdDiTlkbcrOxMmcsq7-w2nqfhO9-0sfw63g0wlAsTD0GUYbyoujHefysHd1ZKVWxt8-v1z3_8XP2PaWlQ</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>Rowe, D C</creator><creator>Van den Oord, E J C G</creator><creator>Stever, C</creator><creator>Giedinghagen, L N</creator><creator>Gard, J M C</creator><creator>Cleveland, H H</creator><creator>Gilson, M</creator><creator>Terris, S T</creator><creator>Mohr, J H</creator><creator>Sherman, S</creator><creator>Abramowitz, A</creator><creator>Waldman, I D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</title><author>Rowe, D C ; Van den Oord, E J C G ; Stever, C ; Giedinghagen, L N ; Gard, J M C ; Cleveland, H H ; Gilson, M ; Terris, S T ; Mohr, J H ; Sherman, S ; Abramowitz, A ; Waldman, I D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2717-9dd97869930cba7e3db423670dab7aea07afeaae2a9693919f4132a64a3c8e5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Alleles</topic><topic>Attention Deficit Disorder with Hyperactivity - genetics</topic><topic>Attention deficit disorders. Hyperactivity</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Behavioral Sciences</topic><topic>Biological and medical sciences</topic><topic>Biological Psychology</topic><topic>Brain Chemistry - genetics</topic><topic>Child</topic><topic>Child clinical studies</topic><topic>Children</topic><topic>Dopamine D2 receptors</topic><topic>Family Health</topic><topic>Female</topic><topic>Gene polymorphism</topic><topic>Genetic Linkage</topic><topic>Genotype</topic><topic>Heritability</topic><topic>Humans</topic><topic>Hyperactivity</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosciences</topic><topic>original-research-article</topic><topic>Pharmacotherapy</topic><topic>Polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Population genetics</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Siblings</topic><topic>Statistical analysis</topic><topic>Taq Polymerase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rowe, D C</creatorcontrib><creatorcontrib>Van den Oord, E J C G</creatorcontrib><creatorcontrib>Stever, C</creatorcontrib><creatorcontrib>Giedinghagen, L N</creatorcontrib><creatorcontrib>Gard, J M C</creatorcontrib><creatorcontrib>Cleveland, H H</creatorcontrib><creatorcontrib>Gilson, M</creatorcontrib><creatorcontrib>Terris, S T</creatorcontrib><creatorcontrib>Mohr, J H</creatorcontrib><creatorcontrib>Sherman, S</creatorcontrib><creatorcontrib>Abramowitz, A</creatorcontrib><creatorcontrib>Waldman, I D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rowe, D C</au><au>Van den Oord, E J C G</au><au>Stever, C</au><au>Giedinghagen, L N</au><au>Gard, J M C</au><au>Cleveland, H H</au><au>Gilson, M</au><au>Terris, S T</au><au>Mohr, J H</au><au>Sherman, S</au><au>Abramowitz, A</au><au>Waldman, I D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>4</volume><issue>6</issue><spage>580</spage><epage>586</epage><pages>580-586</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings ( n  = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h 2  = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10578241</pmid><doi>10.1038/sj.mp.4000567</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-4184
ispartof Molecular psychiatry, 1999-11, Vol.4 (6), p.580-586
issn 1359-4184
1476-5578
language eng
recordid cdi_proquest_miscellaneous_69333900
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adolescent
Adult
Alleles
Attention Deficit Disorder with Hyperactivity - genetics
Attention deficit disorders. Hyperactivity
Attention deficit hyperactivity disorder
Behavioral Sciences
Biological and medical sciences
Biological Psychology
Brain Chemistry - genetics
Child
Child clinical studies
Children
Dopamine D2 receptors
Family Health
Female
Gene polymorphism
Genetic Linkage
Genotype
Heritability
Humans
Hyperactivity
Male
Medical sciences
Medicine
Medicine & Public Health
Neurosciences
original-research-article
Pharmacotherapy
Polymorphism
Polymorphism, Genetic
Population genetics
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Receptors, Dopamine D2 - genetics
Siblings
Statistical analysis
Taq Polymerase
title The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20DRD2%20TaqI%20polymorphism%20and%20symptoms%20of%20attention%20deficit%20hyperactivity%20disorder&rft.jtitle=Molecular%20psychiatry&rft.au=Rowe,%20D%20C&rft.date=1999-11-01&rft.volume=4&rft.issue=6&rft.spage=580&rft.epage=586&rft.pages=580-586&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/sj.mp.4000567&rft_dat=%3Cproquest_cross%3E2645752023%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2645752023&rft_id=info:pmid/10578241&rfr_iscdi=true